|
Immediately preceding Structure-Based
Drug Design, June 15-16
Join the team of top experts and discuss hot topics such
as:
• Enabling Structure-Based Drug Design
• Furthering Target Identification
• Developing Selective Inhibitors of Various Kinase Targets
• Utilization of Kinase Structures and Inhibitors to Enable Increasingly
Selective Drug Targeting
• New Insights into Conformational Variability Between Kinases
• Case Studies
• Kinase Profiling
|
Scientific Advisory Board:
Dr. Alison Henry Joly, Senior Director, Lead Discovery, Exelixis Inc.
Dr. Ralph Lambalot, Director, Protein Biology, Pfizer Inc.
Dr. R. Hannes Niedner, PKR Project Manager & Technical Lead, University of California, San Diego |
| Pharmaceutical
Presentations Include:
|
|
• Abbott Laboratories
• ACADIA Pharma
• AstraZeneca
• Aureus Pharma
• Bayer Healthcare
• CGI Pharmaceuticals
|
• Eli Lilly and Company
• Exelixis
• Merck
• Pfizer Global
• Schering
• Semafore Pharma |
|
For more information, please contact:
Margit Eder, Ph.D., Conference Director
Phone: 781-972-5478 • E-mail: meder@healthtech.com
For exhibit and sponsorship information, please contact:
Suzanne Carroll, Manager, Business Development
781-972-5452 • scarroll@healthtech.com
|
